Clinical Trials Logo

Asthenia clinical trials

View clinical trials related to Asthenia.

Filter by:

NCT ID: NCT03810768 Recruiting - Critical Illness Clinical Trials

Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness

MIRACLE I
Start date: September 2, 2022
Phase:
Study type: Observational

In this mono-center pilot trial, surgical patients who are at high risk to be admitted to intensive care will be screened and asked for participation. We are going to take blood and muscle samples at respecified time points to do metabolic, histological and molecular testing. Aim of the study is to investigate (1) changes of the blood metabolome in patients with ICUAW (intensive care unit acquired weakness) and (2) identify metabolic components who are responsible for ICUAW or can be used as marker for ICUAW.

NCT ID: NCT03143413 Recruiting - Systemic Sclerosis Clinical Trials

Echo Systemic Sclerosis

Start date: March 24, 2017
Phase:
Study type: Observational

Systemic sclerosis is an autoimmune connective tissue disease with undefined etiology and characterized by progressive fibrosis of the skin and major organs. Dry eyes and / or buccal syndrome is commonly reported in patients with systemic sclerosis. Goujerot-Sjogren syndrome is a chronic autoimmune disorder that is characterized by dryness of the eyes (xerophthalmia) and / or mouth (xerostomia). It may be primary or secondary to another connective tissue disease (such as lupus, rheumatoid arthritis or other). Several criteria have been validated to classify the SS but require a labial salivary gland biopsy, invasive act which complications can sometimes be reported (hematoma, lip sensory defect). Several scores based on the evaluation of the ultrasound homogeneity of the salivary glands were developed but no studies have evaluated ultrasound abnormalities of salivary glands in patients with systemic sclerosis.

NCT ID: NCT02363075 Recruiting - Glioma Clinical Trials

Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Asthenia

DXA
Start date: April 2013
Phase: Phase 3
Study type: Interventional

The main purpose of this study is to estimate the efficiency at 3 months of dexamfetamine sulphate on the MFI 20 scale in severe fatigue of patients with stabilized gliomas.